Single-cell epigenetic profiling reveals an interferon response-high program associated with BAP1 deficiency in kidney cancer.

Autor: Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Harvard Graduate Program in Biophysics, Boston, MA 02115, USA., Cuoco MS; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Bioinformatics and Systems Biology Graduate Program, University of California, San Diego, CA 92093, USA., Saad E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Pimenta E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Meli K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Harvard Division of Medical Sciences PhD Program in Biological and Biomedical Sciences, Boston, MA 02115, USA., Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Titchen BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Harvard Division of Medical Sciences PhD Program in Biological and Biomedical Sciences, Boston, MA 02115, USA., Kang YJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA., Horst J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Trowbridge R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Shannon E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Helvie K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Thorner AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Vigneau S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Mayorga A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Kodali J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Lachmayr H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Bemus M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Choueiri T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Nov 18. Date of Electronic Publication: 2024 Nov 18.

Deep Brain Ultrasound Ablation Thermal Dose Modeling with in Vivo Experimental Validation.

Autor: Zhao Z; Worcester Polytechnic Institute, Worcester, MA., Szewczyk B; Worcester Polytechnic Institute, Worcester, MA.; Department of Neurosurgery, Albany Medical Center, Albany, NY., Tarasek M; GE Global Research Center, Niskayuna, NY., Bales C; Worcester Polytechnic Institute, Worcester, MA., Wang Y; Worcester Polytechnic Institute, Worcester, MA., Liu M; Worcester Polytechnic Institute, Worcester, MA., Jiang Y; Worcester Polytechnic Institute, Worcester, MA., Bhushan C; GE Global Research Center, Niskayuna, NY., Fiveland E; GE Global Research Center, Niskayuna, NY., Campwala Z; Department of Neuroscience and Experimental Therapeutics, Albany Medical Center, Albany, NY., Trowbridge R; Department of Neuroscience and Experimental Therapeutics, Albany Medical Center, Albany, NY., Johansen PM; Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL., Olmsted Z; Department of Neuroscience and Experimental Therapeutics, Albany Medical Center, Albany, NY., Ghoshal G; Acoustic MedSystems, Inc., Savoy, IL., Heffter T; Acoustic MedSystems, Inc., Savoy, IL., Gandomi K; Worcester Polytechnic Institute, Worcester, MA., Tavakkolmoghaddam F; Worcester Polytechnic Institute, Worcester, MA., Nycz C; Worcester Polytechnic Institute, Worcester, MA., Jeannotte E; Animal Resources Facility, Albany Medical Center, Albany, NY., Mane S; Department of Neuroscience and Experimental Therapeutics, Albany Medical Center, Albany, NY., Nalwalk J; Department of Neuroscience and Experimental Therapeutics, Albany Medical Center, Albany, NY., Burdette EC; Acoustic MedSystems, Inc., Savoy, IL., Qian J; Department of Neurosurgery, Albany Medical Center, Albany, NY.; Department of Neuroscience and Experimental Therapeutics, Albany Medical Center, Albany, NY., Yeo D; GE Global Research Center, Niskayuna, NY., Pilitsis J; Department of Neurosurgery, Albany Medical Center, Albany, NY.; Department of Neuroscience and Experimental Therapeutics, Albany Medical Center, Albany, NY.; Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL., Fischer GS; Worcester Polytechnic Institute, Worcester, MA.

Publikováno v: ArXiv [ArXiv] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.

1182P Determination of tumor PSMA expression in prostate cancer from blood using a novel epigenomic liquid biopsy platform

Autor: Ravi, P., D'Ippolito, A., Wurster, J., Savignano, H., Stoltenberg, H.A., Trowbridge, R., Borges, N., Tamakloe, T., Kieft, S., Tran, V., Guess, J., Obrien, C., Coyne, M., Gorthi, A., Painter, C., Freedman, M., Eaton, M., Barrett, J.C., Jacene, H., Berchuck, J.E.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S765-S766

The effects of low intensity focused ultrasound on neuronal activity in pain processing regions in a rodent model of common peroneal nerve injury.

Autor: Bao J; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, United States., Byraju K; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, United States., Patel VJ; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, United States., Hellman A; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, United States., Neubauer P; Acoustic Medical Systems, Savoy, IL, United States., Burdette C; Acoustic Medical Systems, Savoy, IL, United States., Rafferty E; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, United States., Park YL; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, United States., Trowbridge R; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, United States., Shin DS; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, United States., Pilitsis JG; Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, United States; Department of Neurosurgery, Albany Medical Center, Albany, NY, United States. Electronic address: jpilitsis@yahoo.com.

Publikováno v: Neuroscience letters [Neurosci Lett] 2022 Oct 15; Vol. 789, pp. 136882. Date of Electronic Publication: 2022 Sep 21.

Deep Sweet Syndrome Secondary to Pegfilgrastim.

Autor: Clarey D, DiMaio D, Trowbridge R

Publikováno v: Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2022 Apr 01; Vol. 21 (4), pp. 422-424.